Status:
UNKNOWN
Timing of Ambulation and Infant Birth Weight in Gestational Diabetes
Lead Sponsor:
Women and Infants Hospital of Rhode Island
Conditions:
Gestational Diabetes
Pregnancy Complications
Eligibility:
FEMALE
18-50 years
Phase:
NA
Brief Summary
This is a randomized controlled trial to assess the effect of routine exercise counseling compared to the recommendation for postprandial ambulation on infant birthweight among pregnant people with ge...
Detailed Description
This is a randomized controlled trial of postprandial ambulation to decrease birthweight percentile in patients with gestational diabetes. Patients who are diagnosed with gestational diabetes. and en...
Eligibility Criteria
Inclusion
- Patients who are diagnosed with gestational diabetes and receive care at the Maternal Fetal Medicine Diabetes in Pregnancy Program and who are fluent in English or Spanish.
Exclusion
- Pre-existing type 1 or type 2 diabetes, and those diagnosed with gestational diabetes in the first trimester. Patients who are either physically unable to ambulate or who have other contraindications to ambulation.
Key Trial Info
Start Date :
October 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06157684
Start Date
October 1 2022
End Date
December 31 2024
Last Update
December 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Women & Infants Hospital of Rhode Island
Providence, Rhode Island, United States, 02905